Moxiclav (Amoxicillin, Clavulanic Acid)

Amoxicillin/clavulanic acid, the active ingredient in Moxiclav, is a penicillin beta‑lactam antibiotic with a beta‑lactamase inhibitor presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults and children.

GNH USA supplies Moxiclav as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across global markets with consistent quality and regulatory adherence. Our distribution network ensures reliable delivery and supports local healthcare providers in meeting antimicrobial therapy needs. We adhere to stringent quality standards throughout the supply chain.

Moxiclav is indicated for bacterial infections that involve the respiratory, urinary, skin, sinus, and middle‑ear pathways.

- Respiratory tract infections: effective against common bacterial causes such as streptococci and Haemophilus, helping to resolve cough, sputum and fever. - Urinary tract infections: eradicates susceptible uropathogens, reducing dysuria and pyuria. - Skin and soft tissue infections: treats cellulitis, abscesses and wound infections caused by susceptible organisms. - Sinusitis: clears bacterial sinus inflammation, improving nasal discharge and facial pain. - Otitis media: eliminates middle‑ear bacterial pathogens, relieving ear pain and hearing impairment.

Moxiclav may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Diarrhea: loose stools occurring during therapy. - Nausea: feeling of stomach upset often accompanied by loss of appetite. - Rash: mild skin erythema or itching. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction with airway compromise. - Clostridioides difficile‑associated colitis: severe diarrhea due to overgrowth of toxin‑producing bacteria. - Hepatic injury: elevated liver enzymes or jaundice indicating liver stress.

Before prescribing Moxiclav, clinicians should consider several safety factors.

- Allergy assessment: avoid in patients with known hypersensitivity to penicillins or clavulanic acid. - Renal function: dose adjustment may be required in severe renal impairment. - Hepatic function: monitor liver enzymes during prolonged therapy. - Pregnancy and lactation: use only if the expected benefit justifies potential risk. - Drug interactions: review concomitant medications for possible interactions. - Store at below 25°C: keep in the original pack, protect from moisture.

Moxiclav can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Probenecid: may increase amoxicillin plasma concentrations, raising toxicity risk. - Methotrexate: can reduce clearance, leading to enhanced toxicity. - Oral contraceptives: may reduce hormonal efficacy, increasing pregnancy risk.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Allopurinol: may increase the likelihood of skin rash, necessitating observation.